104 related articles for article (PubMed ID: 12774246)
1. Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines.
Heinen A; Brüss M; Bönisch H; Göthert M; Molderings GJ
Int J Colorectal Dis; 2003 Jul; 18(4):314-9. PubMed ID: 12774246
[TBL] [Abstract][Full Text] [Related]
2. Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines.
Molderings GJ; Bruss M; Bonisch H; Gothert M
Ann N Y Acad Sci; 2003 Dec; 1009():75-81. PubMed ID: 15028572
[TBL] [Abstract][Full Text] [Related]
3. Agmatine and putrescine uptake in the human glioma cell line SK-MG-1.
Molderings GJ; Bönisch H; Göthert M; Brüss M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):671-9. PubMed ID: 11414662
[TBL] [Abstract][Full Text] [Related]
4. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Hayer-Zillgen M; Brüss M; Bönisch H
Br J Pharmacol; 2002 Jul; 136(6):829-36. PubMed ID: 12110607
[TBL] [Abstract][Full Text] [Related]
5. Exposure of rat isolated stomach and rats in vivo to [(14)C]agmatine: accumulation in the stomach wall and distribution in various tissues.
Molderings GJ; Heinen A; Menzel S; Göthert M
Fundam Clin Pharmacol; 2002 Jun; 16(3):219-25. PubMed ID: 12165069
[TBL] [Abstract][Full Text] [Related]
6. Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2).
Gründemann D; Hahne C; Berkels R; Schömig E
J Pharmacol Exp Ther; 2003 Feb; 304(2):810-7. PubMed ID: 12538837
[TBL] [Abstract][Full Text] [Related]
7. Intestinal tumor and agmatine (decarboxylated arginine): low content in colon carcinoma tissue specimens and inhibitory effect on tumor cell proliferation in vitro.
Molderings GJ; Kribben B; Heinen A; Schröder D; Brüss M; Göthert M
Cancer; 2004 Aug; 101(4):858-68. PubMed ID: 15305420
[TBL] [Abstract][Full Text] [Related]
8. Agmatine uptake by cultured hamster kidney cells.
del Valle AE; Paz JC; Sánchez-Jiménez F; Medina MA
Biochem Biophys Res Commun; 2001 Jan; 280(1):307-11. PubMed ID: 11162515
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Zhang L; Schaner ME; Giacomini KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
[TBL] [Abstract][Full Text] [Related]
11. Expression of human organic cation transporter 3 in kidney carcinoma cell lines increases chemosensitivity to melphalan, irinotecan, and vincristine.
Shnitsar V; Eckardt R; Gupta S; Grottker J; Müller GA; Koepsell H; Burckhardt G; Hagos Y
Cancer Res; 2009 Feb; 69(4):1494-501. PubMed ID: 19190342
[TBL] [Abstract][Full Text] [Related]
12. Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle.
Mayeur C; Veuillet G; Michaud M; Raul F; Blottière HM; Blachier F
Biochim Biophys Acta; 2005 Aug; 1745(1):111-23. PubMed ID: 16085059
[TBL] [Abstract][Full Text] [Related]
13. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).
Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M
Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091
[TBL] [Abstract][Full Text] [Related]
14. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.
Wolf C; Brüss M; Hänisch B; Göthert M; von Kügelgen I; Molderings GJ
Mol Pharmacol; 2007 Jan; 71(1):276-83. PubMed ID: 17047095
[TBL] [Abstract][Full Text] [Related]
16. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
17. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of agmatine on proliferation of tumor cells by modulation of polyamine metabolism.
Wang JF; Su RB; Wu N; Xu B; Lu XQ; Liu Y; Li J
Acta Pharmacol Sin; 2005 May; 26(5):616-22. PubMed ID: 15842783
[TBL] [Abstract][Full Text] [Related]
19. Agmatine transport into spinal nerve terminals is modulated by polyamine analogs.
Goracke-Postle CJ; Overland AC; Stone LS; Fairbanks CA
J Neurochem; 2007 Jan; 100(1):132-41. PubMed ID: 17227436
[TBL] [Abstract][Full Text] [Related]
20. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
